文献速递腹部MR

LI-RADS v2018主要标准:NASH相关HCC与病毒性慢性肝病相关HCC的MRI表现比较

LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?
PubMed 文献 · Eur J Radiol · 2021-03-11

本研究回顾性比较41例NASH相关HCC与41例病毒性慢性肝病相关HCC的MRI,评估LI-RADS v2018主要标准及分类的适用性。两组在影像表现、各主要标准出现率及LI-RADS分类上均无显著差异,提示LI-RADS v2018诊断算法可用于NASH患者。

要点

  • NASH相关HCC与病毒相关HCC的LI-RADS v2018主要标准出现率无显著差异。
  • 两组最常见表现均为动脉期高增强和T2WI可见,NASH组分别为93%和85%。
  • LI-RADS分类在NASH组的读者间一致性强(kappa=0.802),病毒组为中等(kappa=0.720)。

关键影像表现/征象

  • 两组最常见表现均为动脉期高增强,NASH组93% vs 病毒组98%(P=0.616)。
  • 两组T2WI可见分别为NASH组85% vs 病毒组88%(P=1.000)。
  • 两组的定性和定量变量均无显著差异。

诊断标准与关键数值

  • LI-RADS v2018任一主要标准在两组间的出现率均无差异。
  • LI-RADS分类在两组间无差异(P=0.303)。
  • LI-RADS分类读者间一致性:NASH组kappa=0.802(强),病毒组kappa=0.720(中等)。

临床应用与阅片要点

  • LI-RADS v2018主要标准及分类可用于NASH相关HCC的MRI评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: LI-RADS v2018 diagnostic system is used to diagnose hepatocellular carcinoma (HCC) in at risk patients. However, its applicability to HCC in non-alcoholic steatohepatitis (NASH) has not been specifically studied. The purpose of this study was to assess the applicability of LI-RADS v2018 diagnostic system for HCC in patients with NASH.

MATERIALS AND METHODS: The MRI examinations of 41 patients with HCC and NASH (NASH group) were reviewed and compared to those obtained in 41 patients with HCC and virus-induced chronic liver disease (Virus group). MRI examinations of the two groups were compared for imaging presentation, LI-RADS major criteria and LI-RADS categorization. Qualitative variables were compared using Fisher exact test and quantitative variables using Mann-Whitney U test Interreader agreement was assessed using kappa statistic.

RESULTS: No significant differences in qualitative and quantitative variables were observed between the two groups. Most common findings in the two groups were hyperenhancement during the arterial phase and visibility on T2-weighted images (93 % vs. 98 %, P = 0.616 and 85 % vs. 88 %, P = 1.000 for NASH group and Virus group, respectively). No differences in prevalence between the two groups were found for any major LI-RADS v2018 criterion. Interreader agreement for LI-RADS categorization was strong for the NASH group (kappa = 0.802) and moderate for the virus group (kappa = 0.720). No differences were found between the two groups for LI-RADS categories (P = 0.303).

CONCLUSIONS: The LI-RADS v2018 diagnostic algorithm can be applied in patients with NASH.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Barat M, Nguyen TTL, Hollande C, et al. LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI? Eur J Radiol. 2021. PMID: 33740627. doi:10.1016/j.ejrad.2021.109651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。